MeepMorp@lemmy.worldtoNews@lemmy.world•Second Alzheimer's drug in the pipeline promises to slow worsening but with safety concern
1·
1 year ago“Both donanemab and Leqembi are lab-made antibodies, administered by IV, that target one Alzheimer’s culprit, sticky amyloid buildup in the brain. And both drugs come with a serious safety concern — brain swelling or bleeding that in the Lilly study was linked to three deaths.”
I guess compared to your situation, they’re fantastic. I have a static IP and copper connection, but they don’t offer any symmetric plans. I’m stuck with 200down/15up and the best up they offer is 500down/25up.